Category Portal
    • Home
    • World News
    • Hollywood
    • Cryptocurrency
    • Business
    • Economy
    • Finance
    • Sports
    • Digital Marketing
    • DMCA Policy
    • Contact Us
    Category Portal
    Home»Economy»Stocks making the biggest premarket moves: Ferrari, Apple, KB Home and more
    Economy

    Stocks making the biggest premarket moves: Ferrari, Apple, KB Home and more

    By adminMarch 7, 2023No Comments0 Views
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    107000252 1642013445798 gettyimages 1364257709 09i9991 0cab2481 16c3 43a4 aacd 8ee99b1cd911
    Share
    Facebook Twitter LinkedIn Pinterest Email Telegram WhatsApp

    Signs are posted in front of homes under construction at a KB Home housing development on January 12, 2022 in Novato, California.

    Justin Sullivan | Getty Images

    Check out the companies making the biggest moves in premarket trading:

    Ferrari — Shares of the luxury automaker rose less than 1% early Monday after Morgan Stanley analyst Adam Jonas named it a top pick, replacing Tesla. In a note to clients, Jonas cited Ferrari’s backlog and pricing power as reasons to raise his price target on the stock by more than 10%.

    apple — The iPhone maker advanced 2% premarket after Goldman Sachs initiated coverage with a buy rating, saying Apple could get a big boost from its services business. The Wall Street bank’s 12-month price target of $199 implies Apple could rally more than 30% from here.

    KB Home — The homebuilder slipped 1.4% following a double downgrade to underweight from overweight by JPMorgan. The firm cited the stock’s expensive valuation.

    Dr Horton — DR Horton, another homebuilder, fell a little more than 1% after it was downgraded by JPMorgan to neutral from overweight. Analysts said the stock’s premium valuation fairly reflected its above-average fundamental profile and expect the stock to only perform in-line with peers.

    Vir Biotechnology — The biotech gained 5% after JPMorgan upgraded it to overweight from neutral. The bank said Vir has long-term pipeline opportunities across numerous disease indications.

    Silvergate Capital — The bank continued its slide, dropping about 8% premarket. Last week, Silvergate Capital warned of its ability to continue as a going concern and delayed filing its annual report.

    — CNBC’s Yun Li and Jesse Pound contributed reporting.

    Original Content

    Apple Inc Breaking News: Markets Business business news DR Horton Inc Economics Ferrari NV KB Home MarketInsider Markets Silvergate Capital Corp stock markets Vir Biotechnology Inc.
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleMarlon Wayans hopes Chris Rock and Will Smith can come together after Oscars slap: “We can’t just let that sit there”
    Next Article Pathaan Box Office Day 40: Enjoys Another Good Jump On 6th Sunday, Is The Sole Film Collecting In Theatres

    Related Posts

    JPMorgan vs. Bank of America? Analysts say one of the stocks is set to soar 50%

    March 21, 2023

    First Republic Bank woes mount despite Wall Street rescue

    March 21, 2023

    Prince Harry, Meghan were asked to stay in Britain, pretend everything is ‘normal’

    March 21, 2023

    Leave A Reply Cancel Reply

    Advertisement
    Advertisement
    Advertisement
    • Home
    • About Us
    • Disclaimer
    • Privacy Policy
    • Terms of Use
    • Contact Us
    • DMCA Policy
    © 2023 Category Portal | All Rights Reserved

    Type above and press Enter to search. Press Esc to cancel.